Suchergebnisse - "Galus, Ryszard"

PubPharm (57)

1

Two Phase 3, Randomized, Controlled Trials of Ruxolitinib Cream for Vitiligo

enthalten in: The New England journal of medicine | 2022

von Rosmarin, D. | Passeron, T. | Pandya, A. | +109

CommentIn: N Engl J Med. 2022 Oct 20;387(16):1515-1516. - PMID 36260796

2

Dupilumab Provides Acceptable Safety and Sustained Efficacy for up to 4 Years in an Open-Label Study of Adults with Moderate-to-Severe Atopic Dermatitis

enthalten in: American journal of clinical dermatology | 2022

von Beck, L. | Deleuran, M. | Bissonnette, R. | +11

3

Novel diagnostic and prognostic factors for the advanced melanoma based on the glycosylation-related changes studied by biophysical profiling methods

enthalten in: Biosensors & bioelectronics | 2022

von Sobiepanek, A. | Kowalska, P. | Szota, M. | +6

4

Dupilumab Provides Acceptable Safety and Sustained Efficacy for up to 4 Years in an Open-Label Study of Adults with Moderate-to-Severe Atopic Dermatitis

enthalten in: American journal of clinical dermatology | 2022

von Beck, L. | Deleuran, M. | Bissonnette, R. | +11

5

Dupilumab Provides Acceptable Safety and Sustained Efficacy for up to 4 Years in an Open-Label Study of Adults with Moderate-to-Severe Atopic Dermatitis

enthalten in: American journal of clinical dermatology | 2022

von Beck, L. | Deleuran, M. | Bissonnette, R. | +11

6

Dupilumab Provides Acceptable Safety and Sustained Efficacy for up to 4 Years in an Open-Label Study of Adults with Moderate-to-Severe Atopic Dermatitis

enthalten in: American journal of clinical dermatology | 2022

von Beck, L. | Deleuran, M. | Bissonnette, R. | +11

7

Novel therapies in the treatment of atopic dermatitis

enthalten in: Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego | 2021

von Orzołek, I. | Galus, R.

8

A Novel and Effective Method for Human Primary Skin Melanocytes and Metastatic Melanoma Cell Isolation

enthalten in: Cancers | 2021

von Ścieżyńska, A. | Sobiepanek, A. | Kowalska, P. | +9

9

Efficacy and Safety of Abrocitinib in Combination With Topical Therapy in Adolescents With Moderate-to-Severe Atopic Dermatitis : The JADE TEEN Randomized Clinical Trial

enthalten in: JAMA dermatology | 2021

von Eichenfield, L. | Flohr, C. | Sidbury, R. | +12

ErratumIn: JAMA Dermatol. 2021 Oct 1;157(10):1246. - PMID 34668957

10

Single Dose of N-Acetylcysteine in Local Anesthesia Increases Expression of HIF1α, MAPK1, TGFβ1 and Growth Factors in Rat Wound Healing

enthalten in: International journal of molecular sciences | 2021

von Paskal, W. | Kopka, M. | Stachura, A. | +8

1
2
3
4
5
6
Nächster »
[6]